{"id":"NCT02276222","sponsor":"Sunovion Respiratory Development Inc.","briefTitle":"A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD","officialTitle":"A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10","primaryCompletion":"2016-02","completion":"2016-02","firstPosted":"2014-10-28","resultsPosted":"2018-03-13","lastUpdate":"2018-03-13"},"enrollment":1087,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"interventions":[{"type":"DRUG","name":"SUN-101 50 mcg BID eFlow (CS) nebulizer","otherNames":["Glycopyrrolate"]},{"type":"DRUG","name":"Spiriva® 18 mcg QD Handihaler","otherNames":["(tiotropium)"]}],"arms":[{"label":"SUN-101 50 mcg BID eFlow (CS) nebulizer","type":"EXPERIMENTAL"},{"label":"Spiriva 18 mcg QD Handihaler","type":"ACTIVE_COMPARATOR"}],"summary":"This is a long-term safety trial of 48 weeks. Eligible subjects will enter the 48-week, open-label treatment period to receive one of two treatments (SUN-101 given as 50 mcg twice a day or Spiriva® \\[tiotropium\\] given as 18 mcg once a day).","primaryOutcome":{"measure":"Number of Subjects With Treatment-emergent Adverse Events (TEAE)","timeFrame":"Up to Week 48","effectByArm":[{"arm":"SUN-101 50 mcg BID eFlow (CS) Nebulizer","deltaMin":430,"sd":null},{"arm":"Spiriva 18 mcg QD Handihaler","deltaMin":312,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":118,"countries":["United States","Czechia","Hungary","Russia"]},"refs":{"pmids":["28919143","30584583"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":76,"n":620},"commonTop":["chronic obstructive pulmonary disease","cough","upper respiratory tract infection","nasopharyngitis"]}}